PROBLEMS EXISTING IN DIFFERENTIATION THERAPY OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) WITH ALL-TRANS-RETINOIC ACID (ATRA) - DISCUSSION

被引：0
|
作者：
WANG, ZY
CASTAIGNE, S
BERNARD, J
BESSIS, B
CHOMIENNE, C
BEUTLER, E
CRONKITE, EP
DETHE, G
BINET, JL
SACHS, L
BULL, B
DIGHIERO, G
DETHE, H
机构：
[1] HOP ST LOUIS, SERV CLIN MALAD SANG, F-75475 PARIS 10, FRANCE
[2] HOP LA PITIE SALPETRIERE, F-75651 PARIS, FRANCE
[3] HOP ST LOUIS, U93, UNITE RECH IMMUNOGENET TRANSPLANTAT, F-75475 PARIS 10, FRANCE
[4] SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, LA JOLLA, CA 92037 USA
[5] SCRIPPS CLIN, DIV HEMATOL, LA JOLLA, CA 92037 USA
[6] ASSOCIATED UNIV INC, BROOKHAVEN NATL LAB, DEPT MED, UPTON, NY 11973 USA
[7] BROOKHAVEN NATL LAB, DEPT MED, UPTON, NY 11973 USA
[8] INST PASTEUR, UNITE EPIDEMIOL VIRUS ONCOGENES, F-75724 PARIS 15, FRANCE
[9] INST PASTEUR, UNITE EPIDEMIOL VIRUS ONCOGENES, F-75015 PARIS, FRANCE
[10] WEIZMANN INST SCI, DEPT MOLEC GENET & VIROL, IL-76100 REHOVOT, ISRAEL
[11] LOMA LINDA UNIV HOSP, DEPT PATHOL & LAB MED, LOMA LINDA, CA 92350 USA
来源：
BLOOD CELLS | 1993年 / 19卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：642 / 647
页数：6
相关论文
共 50 条
  • [41] RAPID AMELIORATION OF THE COAGULOPATHY IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) TREATED WITH A COMBINATION OF ALL-TRANS-RETINOIC ACID (ATRA) PLUS IDARUBICIN (AIDA PROTOCOL)
    AVVISATI, G
    DRAGONI, F
    CHISTOLINI, A
    MAZZUCCONI, MG
    PALLOTTA, A
    LATAGLIATA, R
    PETTI, MC
    MANDELLI, F
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1432 - 1432
  • [42] Thrombotic complications in acute promyelocytic leukemia during all-trans-retinoic acid therapy
    Pogliani, EM
    Rossini, F
    Casaroli, I
    Maffe, P
    Corneo, G
    ACTA HAEMATOLOGICA, 1997, 97 (04) : 228 - 230
  • [43] Ileal ulceration during all-trans-retinoic acid therapy for acute promyelocytic leukemia
    Sharma, Sanjeev K.
    Mishra, Pravas
    Seth, Tulika
    Mahapatra, Manoranjan
    LEUKEMIA RESEARCH, 2011, 35 (06) : E89 - E90
  • [44] Superinduction of differentiation of acute promyelocytic leukemia (APL) cells by all-trans retinoic acid (ATRA) and interferon gamma (IFN gamma).
    Waxman, S
    Jing, YK
    Chen, SJ
    Chen, Z
    BLOOD, 1996, 88 (10) : 265 - 265
  • [45] All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia
    Quezada, Gerardo
    Kopp, Lisa
    Estey, Elihu
    Wells, Robert J.
    PEDIATRIC BLOOD & CANCER, 2008, 51 (01) : 133 - 135
  • [46] ALL-TRANS-RETINOIC ACID CHEMOTHERAPY INTERACTIONS IN ACUTE PROMYELOCYTIC LEUKEMIA
    ROBERTS, AW
    SHERIDAN, WP
    GRIGG, AP
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1992, 22 (06): : 704 - 704
  • [47] Interaction of all-trans-retinoic acid with fluconazole in acute promyelocytic leukemia
    Vanier, KL
    Mattiussi, AJ
    Johnston, DL
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (05) : 403 - 404
  • [48] The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia
    Barbui, T
    Finazzi, G
    Falanga, A
    BLOOD, 1998, 91 (09) : 3093 - 3102
  • [49] THE ROLE OF ALL-TRANS-RETINOIC ACID IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
    FENAUX, P
    ACTA HAEMATOLOGICA, 1993, 89 : 22 - 27
  • [50] All-trans-retinoic acid (ATRA) counteracts the adhesion of the human promyelocytic leukemia (APL) NB4 cells to the endothelium
    Marchetti, M
    Barbui, T
    Falanga, A
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2256 - P2256
12345